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Abstract
Background: Patients with acute stroke are particularly vulnerable to delirium episodes. Although delirium
detection is important, no evidence-based recommendations have been established to date on how these patients
should be routinely screened for delirium or which tool should be used for this purpose in this population.
Therefore, the aim of this study was to identify delirium screening tools for patients with acute stroke and to
summarise their accuracy.
Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a
systematic search of Medline, CINAHL and Scopus databases was performed to include: (a) diagnostic test accuracy
studies; (b) evaluating tools detecting delirium among patients with acute stroke; (c) written in English; (d)
published up to September 2018. The included studies were assessed in their quality by using the Quality
Assessment of Diagnostic Accuracy Studies-2.
Results: A total of four studies have been performed to date in the field with a variable quality for the
methodology used and documentation of the accuracy of mainly two tools, as (1) the 4-Assessment Test for
delirium (4AT), reporting a range of sensitivity from 90.2 to 100% and a specificity from 64.5 to 86%; and (2) the
Confusion Assessment Method-Intensive Care Unit (CAM-ICU) showing a sensitivity of 76% (95% Confidence of
Interval [CI] 55–91) and a specificity of 98% (95%CI 93–100). Other tools have been studied as: The Abbreviated
Mental Test-10, the Abbreviated Mental Test short form, the Clock Drawing Test, the Cognitive Examination derived
from the National Institutes of Health Stroke Scale and the Glasgow Coma Scale. Moreover, the use of a single
question—namely, ‘Does this patient have cognitive issues?’ as answered by the multidisciplinary team—has been
subjected to a validation process.
Conclusions: To date a few primary studies have been published to test the accuracy of tools in their ability to
detect post-stroke delirium; among those available, the 4AT and the CAM-ICU tools have been mostly studied.
Research has just started to add evidence to the challenge of detecting and usefully assessing newly-acquired
delirium among stroke patients: therefore, more studies are needed to improve the knowledge and allow a robust
selection of the most useful tool to use in this population.
Keywords: Instruments, Intracerebral Haemorrhage, Ischaemic stroke, Post-stroke delirium, Tools, Sensitivity,
Specificity, Systematic review
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Background
Delirium is a complex syndrome characterised by distur-
bances in attention and awareness, associated with
cognitive alterations (e.g., memory, language, percep-
tion)—which can emerge in hours or days—and tends to
fluctuate in severity over time [1]. Delirium prevalence
has been estimated at around 30% in hospitalised med-
ical patients [2], and its occurrence rate per admission
has been documented to vary from 10 to 31% [3], reach-
ing > 50% among frail elderly patients [4].
Although patients with acute stroke are particularly vulner-
able to the development of this clinical complication [5, 6],
the occurrence of delirium in this population is difficult to
study because of the challenges in its detection [7, 8], while
risk factors, as well as short- and long- term outcomes, have
been studied more often [9], including increased functional
impairments, cognitive decline, length of in-hospital stay and
mortality rates [4].
Aiming at preventing delirium occurrence and at min-
imizing its negative consequences, several clinical guide-
lines have been developed to date e.g., [10, 11] which
generally all recommend early detection of delirium as the
basis to tailor specific interventions. Some recommenda-
tions are also available regarding patients with stroke [12],
although rarely incorporated into stroke care; moreover,
what tool should be used in this field is still an unresolved
issue, challenging clinicians in their attempts to detect de-
lirium early in this target population [13, 14].
To date only one systematic review has been pub-
lished on how delirium should be screened in patients
with acute stroke by summarising evidence available
on sensitivity, specificity, positive and negative pre-
dictive values [13]. However, among the 20 observa-
tional studies included in the above-mentioned
systematic review, none of them was aimed at evalu-
ating tool accuracy properties (e.g., sensitivity, specifi-
city, positive and negative predictive values) among
patients with acute stroke. In addition to the Diag-
nostic and Statistical Manual of Mental Disorders cri-
teria (DSM), other tools have emerged for use in
practice, such as the Confusion Assessment Method
(CAM), the Delirium Rating Scale (DRS), the Mini
Mental State Examination (MMSE) and the Organic
Brain Syndrome scale (OBS scale). However, these
tools have not been validated in this specific target popu-
lation [13]. Furthermore, Carin-Levy et al. [13] highlighted
the heterogeneity of the methods used in delirium detec-
tion across studies, which could also explain the wide dif-
ferences of documented delirium occurrence [13].
Therefore, with the purpose of updating the available re-
view [13], as well as to summarise the evidence available
on tools detecting delirium among patients with acute
stroke according to the documented accuracy properties,
a systematic review has been performed.
Methods
Aims
This study aimed to identify delirium screening tools for
patients with acute stroke and to summarise their accur-
acy properties. Specifically, review aims were to (a) high-
light the quantity and quality of research available on
accuracy properties in the target population; (b) investi-
gate the heterogeneity of test accuracy in the included
studies; (c) identify gaps in the evidence available and
determine where further research is required.
Study design
A systematic review of the literature was performed in
accordance to the Preferred Reporting Items for System-
atic Reviews and Meta-Analysis (PRISMA) guidelines
[15]; moreover, the protocol guidance concerning test
accuracy systematic reviews on problems that have a
cognitive focus, was followed [16].
Literature search
Medline, the Cumulative Index to Nursing and Allied
Health Literature (CINAHL) and the Scopus databases
were searched up to September 2018 with the following
MeSH terms and/or keywords combined with the Boolean
operator AND/OR: (a) “Stroke”, “Delirium/diagnosis”,
“Sensitivity and Specificity”, “Neuropsychological Tests”,
“Validation Studies”, “Diagnostic test accuracy studies” in
Medline database; (b) “Stroke”, “Delirium”, “Validation
Studies”, “Neuropsychological Tests”, “Clinical Assess-
ment Tools” in CINAHL database; and (c) “Stroke”, “De-
lirium”, “Screening Tools”, “Screening Tests”, “Validation
Studies”, “Diagnostic test accuracy studies”, “Clinical As-
sessment Tools” in Scopus database. The reference lists of
the retrieved studies were also screened for additional ref-
erences, and studies that published findings of retrieved
study protocols were all hand-searched.
Inclusion and exclusion criteria
Eligible studies were those that satisfied the following in-
clusion criteria: (a) diagnostic test accuracy studies; (b)
evaluating tools detecting delirium among patients with
acute stroke; (c) written in English; and (d) published up
to September 2018. Therefore, there were excluded arti-
cles: (a) reporting protocols regarding diagnostic test ac-
curacy studies; (b) evaluating tools aimed at screening
other cognitive issues in patients with acute stroke (e.g.,
dementia, cognitive decline); (c) analysing the association
between post-stroke delirium and some risk factors or
long-term consequences (e.g., dementia); and (d) not con-
ducted in the acute phase of stroke, established as the first
48 h after the onset to the following two weeks [17].
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Study selection
One researcher (IM) performed the literature search and
two researchers (IM, AP) worked independently to evalu-
ate study eligibility based on title and abstract screening of
each study that emerged. Any differences in the evaluation
regarding eligibility was discussed with a third researcher
(LS). The full texts of eligible studies were then retrieved.
Two researchers (IM, AP) independently evaluated each
study by carefully reading the full text, and the study in-
clusion was decided upon joint agreement. The entire
process of study inclusion is depicted in Fig. 1.
Data extraction
Two researchers (IM, AP) extracted data from each in-
cluded study and populated a study-specific pro forma
reporting the following information: author; year of pub-
lication; study design; country; aim(s); the tool(s) that
was validated and the language of validation; the gold
standard or the alternative methods (e.g., informant in-
terviews, other tools), if any, the tool was validated
against; the diagnostic practices used in the data collec-
tion process, including the timeframe and the setting(s)
where the data collection was performed; who assessed
the patient with the tool(s) (e.g., neurologist, student);
which population was the target and which patients were
involved, by extracting the inclusion and the exclusion
criteria; the sampling method and the main profile (age,
gender) of patients included. Moreover, all diagnostic ac-
curacy properties assessed were also checked and ex-
tracted, such as sensitivity, specificity, positive and
negative predictive values, internal consistency, accuracy,
interrater reliability, likelihood ratio and the Area Under
the Curve (AUC).
On a preliminary fashion, the pro forma used has been
piloted by analysing two studies; then, researchers
worked independently and compared the data extracted
from all studies. Differences were discussed with a third
researcher (LS) and full agreement was reached.
Moreover, given the wide heterogeneity regarding the
terminology used by studies as: screening, detection, as-
sessment, diagnostic tool(a), all aimed at detecting early
the phenomenon of interest to allow appropriate pre-
ventive or treatment interventions, we have used “delir-
ium detection” as an overarching term.
Quality evaluation of the study included
The included studies were evaluated in their quality by
two researchers (IM, AP) using the Quality Assessment
Fig. 1 Flowchart for the search and study selection process (following the PRISMA guidelines) [15]CINAHL The Cumulative Index to Nursing and
Allied Health Literature, PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses.ano studies included in the review were
pertinent to the inclusion criteria.
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of Diagnostic Accuracy Studies-2 (QUADAS-2) [18].
Among different tools available, QUADAS-2 was chosen
as precisely developed for systematic reviews of diagnos-
tic test accuracy studies and recommended by the
Agency for Healthcare Research and Quality, by the
Cochrane Collaboration and by the UK National Insti-
tute for Health and Clinical Excellence [18, 19].
The tool is aimed at evaluating the “Risk of bias” that
occurs if systematic flaws or limitations in (a) the patient
selection, (b) the index test, (c) the reference standard
used, as well as in (d) the flow and timing of the study,
have threaten the findings [18]. The QUADAS-2 tool is
also aimed at evaluating the “Applicability concerns”, as
the extent to which the primary diagnostic test accuracy is
applicable to the research question addressed by the sys-
tematic review. A limited applicability can be diagnosed as
follows: (a) when, as compared with the review question,
the study under evaluation has been conducted in patients
with different demographic and/or clinical characteristics;
(b) when the index test has been applied or interpreted
differently; or (c) when it has been applied with a different
definition of the target condition [18]. Each QUADAS-2
tool’s domain is composed of specific questions that can
be answered as “yes” or “no” according to the evaluation
performed by carefully reading the study. Moreover, the
answer can also be “unclear” when the data available in
the study under evaluation is not adequate.
Results
Characteristics of the studies included
A total of four diagnostic test accuracy studies were in-
cluded in this review (Table 1), of which two [8, 21] had
an additional observational phase and one [20] had an
additional quasi-experimental phase. All studies were pub-
lished from 2012 to 2017, three were conducted in Europe
(Czech Republic [8]; Italy [20]; UK [22]) and one in Russia
[21] and, therefore, validated in different languages.
The included studies developed diagnostic test accuracy
evidence regarding the following tools: the 4-Assessment
Test for delirium (4AT) [20–22], the Confusion Assess-
ment Method for the Intensive Care Unit (CAM-ICU) [8],
the Abbreviated Mental Test, in the complete and in the
short version (AMT-10 and AMT-4) [22], the Clock
Drawing Test (CDT) [22], the Glasgow Coma Scale (GCS)
[22], and the Cognitive examination (COG4) [22]. The fol-
lowing gold standards/alternative tools were considered in
the validation processes undertaken: three studies used
the DSM criteria [8, 20, 21] and one used the CAM [22].
Moreover, delirium detection was performed mainly
by neurologists, neuropsychiatrists or physicians. Mita-
sova et al. [8] involved a panel of specialists who were
considered “delirium experts” for the reference evalu-
ation of delirium. However, the assessment was not al-
ways detailed if it was blinded between the tool under
study and the gold standard/alternative method(s) or if
the assessment was performed by one or several re-
searchers [20, 21].
With regards to the timeframe, Infante et al. [20] used
a single evaluation of delirium, while the remaining
studies [8, 21, 22] performed several assessments; the
follow-up lasted from four days after hospital admission
[22] to the entire length of stay in the hospital [21].
All studies adopted a consecutive sample method using
heterogeneous inclusion criteria. All included patients
with both ischaemic and haemorrhagic stroke and with a
certain degree of consciousness as evaluated by the clinical
team or using the GCS score > 5. However, Infante et al.
[20] excluded patients with aphasia and dementia, while
Mitasova et al. [8] and Kutlubaev et al. [21] also excluded
patients with a history of severe head trauma, neurosur-
gery, brain tumour or significant chronic mental disor-
ders/psychosis.
The study sample sizes were in general small (from 73
to 129 participants), with an age ranging from 71.3 to
79 years. Moreover, all studies were monocentric in na-
ture and performed in hospital units, mainly in Stroke
Units/Stroke centres [8, 20, 22].
Quality evaluation of the studies included
As shown in Table 2, all studies reported a low risk of
concerns in the “Applicability concerns” domain. Con-
versely, among the “Risk of bias”, the “Patient selection”
and the “Reference standard” domains, major concerns
have emerged, respectively due to: the exclusion of pa-
tients with specific characteristics that have potentially af-
fected the representativeness of the sample as, for
example, dementia that has been documented to raise the
risk of delirium [4], and the use of a gold standard tool to
detect delirium not previously validated in patients with
stroke [22]. Moreover, in the same domain, with regards
to the study performed by Infante et al. [20] some con-
cerns emerged regarding the examiner’s knowledge of the
results obtained with the tools under evaluation when
assessing delirium with the gold standard. Kutlubaev et al.
[21] were instead evaluated for unclear risks in the “Index
test” evaluation as it was not possible to assess if the index
test findings were interpreted without knowledge of the
findings of the reference standard, or not.
All studies reported a low risk of bias for the “Flow
and timing” evaluation, and only Mitasova et al. [8] re-
ported an unclear risk of bias because the appropriate-
ness of the interval between the index test and the
reference standard was not documented in the article.
Accuracy properties of the tools
As shown in Table 3, for the 4AT, the studies reported a
sensitivity range of 90.2–100%, a specificity range of 64.5–
86%, a positive predictive value range of 43–86% and a
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negative predictive value range of 85.6–100% [20–22].
Moreover, the AUC was evaluated only for the 4AT, ran-
ging from 0.82 to 0.89 [20, 21].
The CAM-ICU [8] reported a sensitivity of 76% (95%
Confidence Interval [CI] 55–91), a specificity of 98%
(95% CI 93–100), a positive predictive value of 91% (95%
CI 70–99) and a negative predictive value of 94% (95%
CI 88–98). Additionally, Mitasova et al. [8] also esti-
mated that the tool accuracy was 94% (95% CI 88–97)
and had an inter-rater reliability ( ) of 0.94 (95% CI
0.83–1.00), with a re-analysis of ten delirium evaluations
as previously video-taped by an expert, and a likelihood
ratio of 0.47 (0.27–0.83).
Lees et al. [22] evaluated the properties of several
tools, in which the AMT-10 reached a sensitivity of 75%
(95% CI 43–95) and a specificity of 61% (95% CI 51–71),
while the AMT-4 obtained a sensitivity of 83% (95% CI
52–98) and a specificity of 61% (95% CI 51–71). In the
same study, the single question “Does this patient have
cognitive issues?” asked to the healthcare professionals
of the multidisciplinary team reached a sensitivity of
58% (95% CI 28–85) and a specificity of 85% (95% CI
76–92). A detailed report of the accuracy properties has
been shown in Table 3.
Discussion
We have performed a systematic review of diagnostic test
accuracy studies regarding the detection of delirium
among patients with acute stroke. An accurate early detec-
tion of delirium might provide opportunities to identify
high risk patients, to implement evidence-based interven-
tions designed to prevent or minimize delirium occur-
rence, as well as to protect patients against the
consequences of delirium. Moreover, having accurate
tools might also (a) reduce false positive detection, which
may increase the confidence and the following use of the
tool by clinicians, (b) reduce costs in the form of increased
surveillance, as well as (c) reduce harm, as for example,
the burden of the families called to stay at the bedside
when their beloved is detected at high risk of delirium.
With regards to the first aim of this review, despite
stroke patients being particularly vulnerable to delirium
[5, 6] due to direct cerebral insult [23] and the presence
of several risk factors, such as cognitive, visual and func-
tional impairments [6] with an incidence ranging from
13 to 48% [24], only four studies to date, mainly across
Europe, have investigated how to detect the delirium in
these patients. Research validating delirium detection
tools in patients with acute stroke has only started re-
cently. As reported by Carin-Levy [13], no diagnostic
test accuracy studies have been conducted before 2010
and all studies included in our review [8, 20–22] were
published between 2012 and 2017, suggesting an in-
creasing interest in this research field.
Concerning the quality of research studies available,
some methodological limitations have emerged suggest-
ing that further research should follow available guide-
lines (e.g., QUADAS-2, [18]) and assess a minimum set
of accuracy properties allowing a full comparison across
tools. Moreover, in available studies, tools have been
used by physicians, medical students or unspecified
healthcare professionals of a multidisciplinary team—
suggesting that there is a greater source of heterogeneity
in their validation regarding the health care professional
profile. Future studies should also involve clinical nurses
given their presence at the bedside 24/7 who can de-
velop an in-depth knowledge regarding the cognitive sta-
tus of the patients. Furthermore, relatives are often
involved in daily practice as a reference point regarding
the incurred changes in cognition as compared with the
pre-stroke daily life, by detecting weak changes given
their familiarity with the patient: therefore, further stud-
ies should also consider involving family members in the
evaluation of the tool’s accuracy. Their involvement can
also increase (a) the duration of studies and their likeli-
hood to be performed across settings (from acute to
post-acute care), as well as (b) the quality of studies
when family members are involved in the assessment re-
garding the prior clinical conditions (e.g., if patient re-
ported, or not, delirium episodes before the acute
stroke). Moreover, studies performed on this topic fo-
cused their attention on the acute phase of stroke, with
assessments not lasting until the resolution of the delir-
ium condition. Without long-term follow-ups, the
strength of delirium condition detection could be uncer-
tain and affect the accuracy properties of the tools.
A total of seven tools detecting delirium have been
validated to date among patients with acute stroke.
However, more than 20 tools have been developed and/
or validated in other fields, such as Intensive Care Units
(e.g., CAM, CAM-ICU), surgery (e.g., CAM, Delirium
Detection Score, Nurses Delirium Screening Checklist,
Delirium Observation Screening Scale), emergency unit
(brief-CAM, Delirium Triage Screen) and oncology/pal-
liative care (e.g., CAM-ICU, Intensive Care Delirium
Screening Checklist) [25, 26]. Several limitations have
been reported among these studies [26] suggesting that
in the field of neuropsychological tests researchers en-
counter great challenges.
The 4AT is the most validated tool in patients with
acute stroke, with studies reporting good accuracy proper-
ties [20–22]. Having a tool with high sensitivity is recom-
mended in the available literature [27] given that it can
ensure an early detection of delirium which has been doc-
umented to be largely underestimated among patients
with acute stroke [20]. Moreover, although a high sensitiv-
ity could lead to an overestimation of the phenomenon
[20], the 4AT can allow immediate intervention at the
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onset of delirium, potentially preventing or minimizing
the consequent negative outcomes. The AUC, calculated
only for the 4AT [20, 21], ranged from 0.82 to 0.89, thus, con-
firming the accuracy of the tool [28] —with a good internal
consistency as measured with the Cronbach alpha [20]— that
suggests the items included measure the same construct.
According to previous studies in the field, the 4AT is a
rapid tool, easy to use for all healthcare professionals
without specific training [25]. In addition, it has been
documented to be adequate for screening patients with
fluctuating levels of consciousness and drowsiness, and
appears to be useful not only in hyperactive but also in
hypoactive delirium [25], which has been widely re-
ported as being underdiagnosed [14, 29]. Additionally,
despite most delirium detection tools requiring a verbal
response, the 4AT properties have been reported to not
change significantly in patients with acute stroke and se-
vere aphasia [22]. Furthermore, the 4AT has been re-
ported to be adequate in the complex identification of
delirium superimposed on dementia [25].
The CAM-ICU has been validated in patients with
acute stroke only by Mitasova et al. [8]. Compared to
the 4AT, the CAM-ICU demonstrated an inferior sensi-
tivity and a higher specificity. Likewise, the 4AT has
been reported to have good accuracy and a high inter-
rater reliability across examiners, properties that cannot
be compared with other tools given that these properties
have only been provided for the CAM-ICU. The Likeli-
hood Ratio data is moderate, thus, suggesting that the
tool is not reliable in detecting the absence of delirium.
The CAM-ICU was originally developed for delirium de-
tection among critically ill patients, specifically those mech-
anically ventilated [30, 31]. Subsequently, the CAM-ICU tool
has been widely validated in emergency, oncology, palliative
and surgical patients [25], which are all considerably different
than stroke patients. The sensitivity and specificity properties
have been reported to be influenced by the health care pro-
fessional’s experience and training [25], thus, suggesting that
the tool requires training [25, 26] to maximise its accuracy
[25]. In contrast to the 4AT, the CAM-ICU allows a limited
assessment of drowsy patients [25], with a potential risk of
underdiagnosing those with hypoactive delirium.
Other delirium detection tools have been validated by
Lees and colleagues [22], such as the AMT-10, the
AMT-4, the CDT, the COG4 and the GCS. All reported
lower psychometric properties as compared with the
4AT and the CAM-ICU, likely because these tools were
not specifically designed for detecting delirium. In fact,
the AMT-10 and its shortened form, AMT-4, allows a
direct cognitive test of mental impairment [32, 33]. The
CDT [34] does not require a verbal response from the
patient, thus, it can be suitable for stroke patients [22],
but it has been shown to be useful in cognition measure-
ment—not in delirium detection [26]. Similarly, the
COG4 is derived from the National Institute of Health
Stroke Scale [35] and adequately designed to evaluate
the cognitive status in patients with acute stroke [35].
The issue is the same regarding the GCS [36], which has
been designed to assess coma and impaired conscious-
ness. Delirium could be a consequence of post-stroke
cognitive impairments [22], but the use of the above-
mentioned tools in detecting delirium among these pa-
tients should be considered with caution.
To date only Lees et al. [22] have tested some proper-
ties of a single question “Does this patient have cognitive
issues?”, which is often used in clinical practice to detect
changes in the patients’ cognition by also interviewing
family caregivers. Data from their study suggested that
this single question has comparable specificity to other
structured tools (e.g., 4AT, CAM-ICU) and superior sen-
sitivity with regards to the CGS.
A further consideration is needed regarding the gold
standard or the alternative measures criteria used across
studies. Infante et al. [20], Kutlubaev et al. [21] and
Mitasova et al. [8] considered the DSM-IV criteria as a
point of reference for the 4AT and the CAM-ICU, re-
spectively. The DSM-IV criteria could be considered as
a gold standard, but need to be performed by experts in
the field, such as neurologists or psychiatrists, and re-
quires special training [21]. Alternatively, Lees and col-
leagues [22] assessed the 4AT properties against the
CAM, although this tool has not been validated in delir-
ium detection among patients with acute stroke.
Therefore, more studies are encouraged in this field to
establish the accuracy of the tools detecting delirium
among patients with acute stroke; alongside, these tools
should be considered inside of the widely clinical exam-
ination of the patients [37].
Strengths and limitations
This systematic review offers an overview of the delirium
detection tools available in the literature regarding pa-
tients with acute stroke, in which the assessment could
be a challenge due to specific neurological symptoms
(e.g. aphasia). Accuracy properties of different tools have
been analysed, as well as the methodological quality of
the studies documenting these properties. However, this
review is affected by several limitations. Firstly, we did
not register and publish the review research protocol in
a public access repository. Moreover, only Medline,
CINAHL, and Scopus databases were searched and only
studies published in English and peer reviewed were in-
cluded, thus introducing a potential source of selection
bias. Authors were not contacted to obtain missing or
incomplete data that was not reported in the included
studies due, for example, to word restrictions imposed
by journal guidelines, and this could have introduced
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information bias and affect the completeness of the qual-
ity evaluation as performed with the QUADAS-2 [18].
Some accuracy properties were heterogeneously re-
ported across studies thus threatening a full comparison
of the findings: for example, 95% CI has been not re-
ported in Kutlubaev et al. (2016) [18] or in Infante et al.
(2017) [20]; moreover, sensitivity and specificity have all
been reported while positive and negative predictive
values were not. Attempts were performed to calculate
the missing metrics, but no reliable findings were ob-
tained due to some missing data in the studies: this
strengthens the need to further adopt guidelines [18] in
reporting test accuracy studies regarding delirium.
Conclusions
The detection of delirium in stroke is complex, given the
challenges of (a) the high occurrence of sensory, perceptual
and communication deficits with stroke, (b) the differentiation
of delirium from more permanent stroke-related acquired
cognitive impairments, and (c) the pre-existing cognitive im-
pairments, given that vascular disease and stroke are risk fac-
tors for both dementia and further stroke. However, having
instruments supporting the clinical judgment is crucial to per-
sonalise pharmacological and non-pharmacological interven-
tions [38, 39] preventing and/or managing this clinical
condition and its negative consequences.
Despite its relevance, to date few primary studies have
been published to test accuracy properties of tools in
their ability to detect post-stroke delirium; among those
available, the 4AT and the CAM-ICU tools have been
mostly studied. However, the small number of studies
retrieved have documented different measures thus pre-
venting comparisons across tools and suggesting that re-
search has just started to add evidence to the challenge
of detecting and usefully assessing newly-acquired delir-
ium in stroke disease. Furthermore, without long-term
follow-ups at least until the resolution of the delirium, it
is uncertain how robust the diagnosis of delirium can be.
Therefore, further studies methodologically sound and
reporting a minimum data set of metrics in order to en-
sure comparison across studies, are strongly recom-
mended. Moreover, alongside the importance of simple
tools in the detection of newly-acquired delirium, a full
consideration of the use of structured informant histor-
ies from either family or nurses and other care staff
should be considered.
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